Recognizing a lifetime of innovation
Rob Burrell has spent his life inventing and innovating—including helping design more than 15 medical processes and products. Before joining UAlberta, Burrell developed Acticoat, the world’s first therapeutic use of nanotechnology. Since then, Acticoat has transformed burn and wound care around the world, saving thousands of lives and limbs. A global healthcare firm acquired Acticoat, which is now used in about 50 countries and represents $1B in sales. Today, he is developing a device to distinguish viral infections from bacterial ones in minutes to help address unnecessary antibiotic use. He is also developing a device to detect thyroid cancer markers.
In recognition of his many achievements, Burrell was recently elected to the (U.S.) National Academy of Inventors, the highest professional distinction accorded to academic inventors.